Collateral damage to normal microbiota, which can be associated with the use of less-specific chemical antibacterials, [4] is avoided. Nonetheless, there are several challenges that must be addressed ...

BiomX announced positive results from Part 1 of its Phase 1b/2a study for its novel phage cocktail, BX004, treating chronic pulmonary infections caused by P. aeruginosa bacteria in Cystic Fibrosis.

Premier research journal article provides validation for BiomX’s phage therapy platform, showcasing first-in-human Phase 1b/2a trial results for antibiotic-resistant P. aeruginosa infectionsNew, ...

Bacteriophages, or phages for short, may be too small to see without an electron microscope, but they have enormous therapeutic potential. Given the bacteria-killing capabilities of phages, the most ...

In a major advance for infectious disease treatment, researchers from Monash University and The Alfred have developed a bespoke phage therapy product that uses bacterial viruses, known as ...

Steffanie Strathdee and her husband Tom Patterson fishing in Haida Gwaii, British Columbia in August 2023. Tom recovered from a life-threatening superbug infection after receiving phage therapy in ...

Oral administration of a cocktail of three viruses, all of which specifically kill cholera bacteria, prevents infection and cholera-like symptoms in animal model experiments, report scientists from ...

In a recent study published in Scientific Reports, researchers investigated whether a cocktail of bacteriophages coding for the depolymerase polysaccharide could effectively disrupt Klebsiella ...

Future Microbiol. 2013;8(6):769-783. The use of phage cocktails can be conceptually differentiated into: efforts that seek to broaden the utility of phage formulations, that is, what diseases or ...